HONG KONG, Dec. 23, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK) has once again raised the bar for sustainability commitment and transparency. The company has been honored by the Hong Kong ESG Reporting Awards (HERA) 2025 for Outstanding ESG Disclosure, marking a new milestone in its dedication to openness and accountability.

This recognition follows last year's ESG Report Benchmark Award from HERA, verifying the consistency of WuXi Biologics' progressive ESG journey. Beyond assuring compliance, ESG reporting is a strategic lever that helps gain trust and strengthen confidence among global clients, investors, regulators, and other stakeholders.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.

Post a comment
Stop watching this discussion.